Joint Destruction in Arthritis: Metalloproteinases the Spotlight

Joint Destruction in Arthritis: Metalloproteinases the Spotlight JOINT DESTRUCTION IN ARTHRITIS: METALLOPROTEINASES IN THE SPOTLIGHT CONSTANCE E . BRINCKERHOFF The erosion of connective tissue (cartilage, tendon, and bone) that accompanies both rheumatoid arthritis (RA) and osteoarthritis (OA) is, unfortunately, well known to physicians and patients alike. This destruction is mediated largely by collagenase and stromelysin, enzymes that are produced by the synovial fibroblasts (1). Collagenase is rate limiting in collagen degradation, while stromelysin degrades noncollagen proteins, e.g., laminin, fibronectin, and proteoglycans. Both enzymes belong to the gene family of metalloproteinases, which comprises at least 10 members (2). All metalloproteinases are active at neutral pH, contain zinc as an integral part of their structure, require Ca++ for activity, and are inhibited by tissue inhibitor of metalloproteinases (TIMP). Thus, TIMP, also a product of synovial fibroblasts, provides a potential mechanism for controlling degradation of the extracellular matrix, but its actual role in modulating disease has been debated. Until now, most of our information on the biochemical and biologic features of these enzymes has been derived from in vitro studies utilizing either From the Department of Medicine and the Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire. Supported by NIH grant AR-26599 and by grants from the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatology Wiley

Joint Destruction in Arthritis: Metalloproteinases the Spotlight

Arthritis & Rheumatology, Volume 34 (9) – Oct 7, 1991

Loading next page...
 
/lp/wiley/joint-destruction-in-arthritis-metalloproteinases-the-spotlight-pZtZ0UMf1G
Publisher
Wiley
Copyright
Copyright © 1991 American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/art.1780340902
Publisher site
See Article on Publisher Site

Abstract

JOINT DESTRUCTION IN ARTHRITIS: METALLOPROTEINASES IN THE SPOTLIGHT CONSTANCE E . BRINCKERHOFF The erosion of connective tissue (cartilage, tendon, and bone) that accompanies both rheumatoid arthritis (RA) and osteoarthritis (OA) is, unfortunately, well known to physicians and patients alike. This destruction is mediated largely by collagenase and stromelysin, enzymes that are produced by the synovial fibroblasts (1). Collagenase is rate limiting in collagen degradation, while stromelysin degrades noncollagen proteins, e.g., laminin, fibronectin, and proteoglycans. Both enzymes belong to the gene family of metalloproteinases, which comprises at least 10 members (2). All metalloproteinases are active at neutral pH, contain zinc as an integral part of their structure, require Ca++ for activity, and are inhibited by tissue inhibitor of metalloproteinases (TIMP). Thus, TIMP, also a product of synovial fibroblasts, provides a potential mechanism for controlling degradation of the extracellular matrix, but its actual role in modulating disease has been debated. Until now, most of our information on the biochemical and biologic features of these enzymes has been derived from in vitro studies utilizing either From the Department of Medicine and the Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire. Supported by NIH grant AR-26599 and by grants from the

Journal

Arthritis & RheumatologyWiley

Published: Oct 7, 1991

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off